background polymorphisms transforming growth factor associated variations cytokine levels linked fibrosis number tissues contribution cytokine organ fibrosis patients cystic fibrosis presently unclear study undertaken examine association gene polymorphisms development pulmonary dysfunction patients cystic fibrosis methods polymorphisms gene defining amino acids codons NUMBER NUMBER determined using dna stored NUMBER caucasian patients homozygous deltaf508 mutation cystic fibrosis transmembrane conductance regulator cftr gene clinical information patients obtained medical records results patients cystic fibrosis high producer genotype codon NUMBER rapid deterioration lung function low producer genotype relative risk accelerated decline forced expiratory volume second fev1 NUMBER predicted forced vital capacity fvc NUMBER predicted patients high producer genotype NUMBER NUMBER ci NUMBER NUMBER NUMBER compared NUMBER NUMBER ci NUMBER NUMBER low producer genotype discussion genotypes role mediating pulmonary dysfunction patients cystic fibrosis work required determine inhibition activity patients slow disease progression tgf beta1 tgf beta1 tgf beta1 arms pcr tgf beta1 tgf beta1 tgf beta1 tgf beta1